SCHEMBL6981541

SCHEMBL6981541

CC1CCN(C(=O)c2ccc3ncccc3c2)CC1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.67
RAB9A P51151 1/20 0.67
HPGD P15428 4/20 0.60
DPP4 P27487 1/20 0.56
DPP8 Q6V1X1 1/20 0.56
CCR3 P51677 5/20 0.56
ALDH1A1 P00352 1/20 0.56
TP53 P04637 1/20 0.56
LMNA P02545 1/20 0.54
ACHE P22303 1/20 0.54
CAPN1 P07384 1/20 0.53
PDE2A O00408 1/20 0.52
ALOX15 P16050 1/20 0.52
HTT P42858 1/20 0.52
PLK1 P53350 1/20 0.52
TSHR P16473 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HTR3A P46098 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16002936 0.86 PLK1 (0.55) NPC1RAB9AHPGDDPP4DPP8
SCHEMBL13889100 0.85 CCR3 (0.61) CCR3LMNA
SCHEMBL6981927 0.85 DPP4 (0.59) NPC1RAB9AHPGDDPP4DPP8
SCHEMBL16000517 0.84 DPP4 (0.54) NPC1RAB9AHPGDDPP4DPP8
SCHEMBL31428431 0.84 CAPN1 (0.55) NPC1RAB9AHPGDDPP4DPP8
SCHEMBL6986208 0.84 HPGD (0.71) HPGDDPP4DPP8ALDH1A1LMNA
SCHEMBL13889099 0.83 L3MBTL3 (0.67) HPGDDPP4DPP8CCR3
SCHEMBL28256059 0.83 HPGD (0.57) HPGDDPP4DPP8CCR3ALDH1A1
SCHEMBL6984876 0.82 MKNK1 (0.62) HPGDDPP4DPP8CCR3ALOX15
SCHEMBL31428565 0.82 RIPK1 (0.60) HPGDDPP4DPP8CCR3ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed